Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View


Elevation Oncology to Present at the Piper Sandler 33rd Annual Virtual


PR Newswire | Nov 18, 2021 08:01AM EST

Healthcare Conference

11/18 07:00 CST

Elevation Oncology to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference NEW YORK, Nov. 18, 2021

NEW YORK, Nov. 18, 2021 /PRNewswire/ -- Elevation Oncology, Inc. (Nasdaq: ELEV), a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, today announced that members of the senior management team will present a corporate overview and participate in one-on-one investor meetings at the Piper Sandler 33rd Annual Virtual Healthcare Conference, taking place November 29, 2021 to December 2, 2021.

An on-demand replay of the presentation can be accessed beginning November 22, 2021 at 10:00 am ET on the Events page of the Company's Investor Relations website at https://investors.elevationoncology.com.

About Elevation Oncology, Inc.

Elevation Oncology is founded on the belief that every patient living with cancer deserves to know what is driving the growth of their disease and have access to therapeutics that can stop it. We aim to make genomic tests actionable by selectively developing drugs to inhibit the specific alterations that have been identified as drivers of tumor growth. Together with our peers, we work towards a future in which each tumor's unique genomic test result can be matched with a purpose-built precision medicine to enable an individualized treatment plan for each patient. Our lead candidate, seribantumab, is intended to inhibit tumor growth driven by NRG1 fusions and is currently being evaluated in the Phase 2 CRESTONE study for patients with solid tumors of any origin that have an NRG1 gene fusion. Details on CRESTONE are available at www.NRG1fusion.com. For more information visit www.ElevationOncology.com.

Elevation Oncology Investor and Media ContactCandice Masse, 978-879-7273Senior Director, Corporate Communications & Investor Relationscmasse@elevationoncology.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/elevation-oncology-to-present-at-the-piper-sandler-33rd-annual-virtual-healthcare-conference-301427298.html

SOURCE Elevation Oncology






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-5
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC